$7.4B Deal Nets Purdue More Time, J&J Spinoff Ends Trial
By Emlyn Cameron · March 3, 2025, 5:23 PM EST
Purdue Pharma received approval for more mediation time after telling a judge that it had reached definitive terms on a new $7.4 billion settlement of opioid claims; a two-week trial over...
To view the full article, register now.